Related references
Note: Only part of the references are listed.The Clinical and Prognostic Importance of Positive Blood Cultures in Adults
Brian C. Pien et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Community-Onset Bacteremia Due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2010)
Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Karen Bush
CURRENT OPINION IN MICROBIOLOGY (2010)
Diversity of Escherichia coli Strains Producing Extended-Spectrum β-Lactamases in Spain: Second Nationwide Study
Miguel A. Diaz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
Jesus Rodriguez-Bano et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Epidemiology and Outcome of Klebsiella Species Bloodstream Infection: A Population-Based Study
Majdi N. Al-Hasan et al.
MAYO CLINIC PROCEEDINGS (2010)
Carbapenem Resistance Among Klebsiella pneumoniae Isolates: Risk Factors, Molecular Characteristics, and Susceptibility Patterns
Khetam Hussein et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007
Majdi N. Al-Hasan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli
Jesus Rodriguez-Bano et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients
Min-Hyok Jeon et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern
Johann D. D. Pitout et al.
LANCET INFECTIOUS DISEASES (2008)
Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia:: a systematic review and meta-analysis
Mitchell J. Schwaber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia
Galo Peralta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli
Cao Bin et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae -: Variability by site of infection
EP Hyle et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum β-lactamase:: Treatment outcome of patients receiving imipenem or ciprofloxacin
A Endimiani et al.
CLINICAL INFECTIOUS DISEASES (2004)
Antibiotic therapy for Klebsiella pneumoniae bacteremia:: Implications of production of extended-spectrum β-lactamases
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2004)
Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections
ND Friedman et al.
ANNALS OF INTERNAL MEDICINE (2002)
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae
KS Thomson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
